Integrated Perspective on Functional Organic Electrochemical Transistors and Biosensors in Implantable Drug Delivery Systems

Abstract

Although traditional drug delivery methods are widely used in clinical practice, their inherent limitations often compromise therapeutic efficacy. Therefore, the development of more precise and efficient drug delivery systems is essential to enhance treatment outcomes and reduce adverse effects. Implantable drug delivery systems (IDDSs) represent intelligent platforms capable of autonomously regulating drug release in response to a patient’s physiological state. By enabling controlled release and personalized dosing, IDDSs have been widely applied in the management of chronic conditions such as diabetes and cancer. With ongoing technological advancements, modern IDDSs must meet increasing demands for both precision delivery and real-time physiological monitoring. In this context, organic electrochemical transistor (OECT)-based biosensors, known for their high sensitivity and excellent real-time signal processing capabilities, have demonstrated significant advantages in early diagnosis and continuous pathological monitoring. While both IDDS and OECT technologies have shown promising progress individually, challenges remain in achieving long-term stability, biocompatibility, scalable manufacturing, and system-level integration. This review systematically summarizes recent advances in IDDSs and functional OECT-based biosensors across various application domains. Furthermore, it explores potential future directions for their combined development, focusing on technological convergence, materials innovation, interdisciplinary collaboration, and the design of intelligent control systems. Looking ahead, the seamless integration of OECT-based biosensors with IDDSs holds the potential to create more precise and efficient closed-loop therapeutic platforms, accelerating progress in the fields of personalized and precision medicine.